Zota Health Care Limited (ZOTA.NS)

INR 883.3

(2.2%)

EBITDA Summary of Zota Health Care Limited

Zota Health Care Limited's latest annual EBITDA in 2023 was 82.07 Million INR , down -18.7% from previous year.
Zota Health Care Limited's latest quarterly EBITDA in 2024 Q1 was -12.58 Million INR , down -20.68% from previous quarter.
Zota Health Care Limited reported an annual EBITDA of 98.04 Million INR in 2022, down -42.36% from previous year.
Zota Health Care Limited reported an annual EBITDA of 164.25 Million INR in 2021, up 783.35% from previous year.
Zota Health Care Limited reported a quarterly EBITDA of N/A for 2023 FY, down -18.7% from previous quarter.
Zota Health Care Limited reported a quarterly EBITDA of -14.85 Million INR for 2023 Q4, down -144.56% from previous quarter.

Annual EBITDA Chart of Zota Health Care Limited (2023 - 2010)

Historical Annual EBITDA of Zota Health Care Limited (2023 - 2010)

Year	EBITDA	EBITDA Growth
2023	82.07 Million INR	-18.7%
2022	98.04 Million INR	-42.36%
2021	164.25 Million INR	783.35%
2020	28.62 Million INR	-69.45%
2019	60.14 Million INR	-37.16%
2018	92.65 Million INR	-23.39%
2017	123.98 Million INR	23.18%
2016	100.5 Million INR	4.32%
2015	95.65 Million INR	14.19%
2014	84.84 Million INR	28.68%
2013	65.15 Million INR	11.56%
2012	59.33 Million INR	0.0%
2010	48.11 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-12.58 Million INR	-20.68%
2023 FY	- INR	-18.7%
2023 Q4	-14.85 Million INR	-144.56%
2023 Q1	14.3 Million INR	35.34%
2023 Q2	48.23 Million INR	237.15%
2023 Q3	33.33 Million INR	-30.9%
2022 Q3	6.43 Million INR	-88.66%
2022 FY	- INR	-42.36%
2022 Q1	19.15 Million INR	239.68%
2022 Q2	56.74 Million INR	196.22%
2022 Q4	10.57 Million INR	64.22%
2021 Q1	51.9 Million INR	101866.67%
2021 FY	- INR	783.35%
2021 Q4	5.64 Million INR	-89.42%
2021 Q3	53.3 Million INR	5.85%
2021 Q2	50.35 Million INR	-2.97%
2020 FY	- INR	-69.45%
2020 Q1	13.82 Million INR	-30.43%
2020 Q2	10.63 Million INR	-23.07%
2020 Q3	-6.15 Million INR	-157.88%
2020 Q4	-51 Thousand INR	99.17%
2019 FY	- INR	-37.16%
2019 Q4	19.86 Million INR	90.9%
2019 Q2	17.94 Million INR	55.86%
2019 Q1	11.51 Million INR	-48.21%
2019 Q3	10.4 Million INR	-42.0%
2018 Q4	22.22 Million INR	408.73%
2018 FY	- INR	-23.39%
2018 Q3	4.36 Million INR	0.0%
2017 FY	- INR	23.18%
2016 Q1	23.83 Million INR	0.0%
2016 FY	- INR	4.32%
2015 FY	- INR	14.19%
2014 FY	- INR	28.68%
2013 FY	- INR	11.56%
2012 FY	- INR	0.0%
2010 FY	- INR	0.0%

Peer EBITDA Comparison of Zota Health Care Limited

Name	EBITDA	EBITDA Difference
Biocon Limited	41.52 Billion INR	99.802%
Blue Jet Healthcare Limited	2.29 Billion INR	96.42%
Concord Biotech Limited	4.65 Billion INR	98.238%
Dishman Carbogen Amcis Limited	3.07 Billion INR	97.328%
Jubilant Ingrevia Limited	4.56 Billion INR	98.202%
Lyka Labs Limited	167.58 Million INR	51.027%
Panacea Biotec Limited	-47.58 Million INR	272.495%
Piramal Pharma Limited	13.05 Billion INR	99.371%
SMS Lifesciences India Limited	349.41 Million INR	76.511%
Supriya Lifescience Limited	1.83 Billion INR	95.529%
Syngene International Limited	10.84 Billion INR	99.243%
TAKE Solutions Limited	-1.05 Billion INR	107.81%